Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026838 (
spasticity
)
6,471
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Background:
Cannabis is increasingly used by persons at end of life to ameliorate symptoms such as pain,
spasticity
, anorexia, or anxiety. Cannabis
hyperemesis
is a distressing adverse effect of chronic use and may cause significant morbidity. Unfortunately, the clinical presentation of this syndrome may be subtle in a person with complex medical issues or disability. Providers must remain vigilant for possible variations in presentation in these populations.
Aim:
To assess literature on cannabis
hyperemesis
and present unique considerations for clinical assessment and treatment for patients at end of life.
Design:
Initial literature scoping yielded limited evidence on the subject in the setting of chronic disease and disability. A case of cannabis
hyperemesis
in a person with advanced amyotrophic lateral sclerosis is presented to illustrate challenges in diagnosis and management in this setting. A narrative synthesis of current literature on assessment and management and special considerations for evaluation and treatment for patients under palliative care was performed.
Results:
Several unique considerations for the diagnosis and management of cannabis
hyperemesis
in palliative care patients are highlighted in the case presented, including: (1) Symptoms may possibly be abolished through decrease rather than complete abstinence from cannabis, (2) Frequent hot baths may not be present in patients with physical impairments in activities of daily living, and (3) Management of primary symptoms (pain,
spasticity
, nausea, and anxiety) in the end-of-life care patient must be considered to maximize comfort.
Conclusion:
The presentation of cannabis
hyperemesis
may be atypical in palliative care patients due to disability. More work is needed to improve risk stratification for patients using cannabis for palliative care.
...
PMID:Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review. 3108 61